Trial Profile
Multicenter, Double-Blind, Parallel, Placebo-Controlled, Randomised Phase 3 Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis: 12-Week Final Data
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Wyeth
- 03 Jan 2007 New trial record.
- 03 Jan 2007 New trial record.